狄诺塞麦一盒有几支？

Bone metastasis is a disease in which certain malignant tumors that originate outside bone tissue metastasize to bone tissue through blood. The main manifestations are bone damage and pain. (Denosumab) is an effective drug for bone metastases after zoledronic acid resistance or adverse reaction intolerance.

The effect of denosumab (denosumab) on bone reconstruction can be evaluated by measuring some bone renewal markers, such as the bone resorption marker N-telopeptide, the bone formation marker bone-specific alkaline phosphatase, etc. A phase I clinical study conducted in healthy postmenopausal women showed that a dose-dependent decrease in morning urine NTX levels was observed on day 2 after administration. This decrease lasted for 6 months, with the maximum decrease reaching 84% compared with baseline. This effect is reversible. When serum denosumab levels disappear, NTX levels can be seen to rise again, which reflects the reversibility of its effect on bone reconstruction. As treatment continues, these effects will persist for a new cycle.

According to the editor of Medical Companion Travel, the price of denosumab (denosumab) in the United States is relatively expensive, and most patient families with average economic levels cannot afford it. In order to reduce medical expenses, most patients choose to buy Amgen’s original drug denosumab (denosumab), which is launched in Turkey. The price is relatively cheap. It is currently the most cost-effective drug in the world and the one that patients buy the most. The specification of Turkish denosumab (denosumab) is 120 mg, and the price is equivalent to RMB 1,500.

In unresectable patients, denosumab (denosumab) resulted in effective long-term disease control, with a 5-year progression-free survival (PFS) rate of 88%. (Denosumab) has brought good news to many patients after its launch, and we also expect it to create more medical value.

Recommended related hot articles: /newsDetail/77903.html